Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

CorMedix (CRMD) Equity Ratio (2016 - 2025)

CorMedix (CRMD) has disclosed Equity Ratio for 13 consecutive years, with 0.49 as the latest value for Q4 2025.

  • Quarterly Equity Ratio fell 31.13% to 0.49 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.49 through Dec 2025, down 31.13% year-over-year, with the annual reading at 0.49 for FY2025, 31.13% down from the prior year.
  • Equity Ratio hit 0.49 in Q4 2025 for CorMedix, down from 0.5 in the prior quarter.
  • In the past five years, Equity Ratio ranged from a high of 0.95 in Q1 2021 to a low of 0.49 in Q4 2025.
  • Historically, Equity Ratio has averaged 0.83 across 5 years, with a median of 0.89 in 2022.
  • Biggest YoY gain for Equity Ratio was 24.41% in 2021; the steepest drop was 88.26% in 2021.
  • Year by year, Equity Ratio stood at 0.91 in 2021, then dropped by 2.56% to 0.89 in 2022, then grew by 2.54% to 0.91 in 2023, then decreased by 21.72% to 0.71 in 2024, then crashed by 31.13% to 0.49 in 2025.
  • Business Quant data shows Equity Ratio for CRMD at 0.49 in Q4 2025, 0.5 in Q3 2025, and 0.87 in Q2 2025.